Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Harvey Norman Holdings (HVN.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (A$) Price Target (A$) Rating
2022-03-305.716.50Buy
2022-06-233.713.35Sell
2022-08-314.233.60Sell
2022-11-244.173.85Sell
2023-02-283.853.60Sell
2023-06-203.323.10Sell
2023-08-083.723.25Sell
2023-09-014.123.75Sell
2023-10-283.723.75Neutral
2024-01-204.304.75Buy
2024-03-015.005.50Buy
2024-09-024.605.00Buy
2024-11-274.905.00Neutral
2025-02-285.225.25Neutral

Disclosures

  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.